microRNA regulation of the expression of the estrogen receptor in endometrial cancer

Molecular Medicine Reports

Volumn 3, Issue 3, 2010, Pages 387-392

  Zhou, Jing ^a   Song, Tianrong ^a   Gong, Shipeng ^a   Zhong, Mei ^a   Su, Guidong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Endometrial cancer; Estrogen dependency; Estrogen receptor ; Microarray; microRNA; Real time RT PCR; Target gene

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MICRORNA; MIR 100; MIR 378; MIR 768 3P; MIR 99A; PROGESTERONE; PROGESTERONE RECEPTOR; RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOPSY; CELL LINE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOLOGY; PREDICTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SAMPLE; TRANSPLANTATION; VALIDATION STUDY;

EUKARYOTA;

EID: 77952324450     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000269     Document Type: Article

References (17)

1. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-71, 1983.
2. Gründker C, Günthert AR and Emons G: Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol 630: 166-188, 2008.
3. Uharcek P: Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res 34: 776-783, 2008.
4. Filip A: miRNA - new mechanisms of gene expression control. Postepy Biochem 53: 413-419, 2007.
5. Bueno MJ, de Castro IP and Malumbres M: Control of cell proliferation pathways by micrornas. Cell Cycle 7: 3143-3148, 2008.
6. Fujimoto J, Hirose R, Sakaguchi H and Tamaya T: Estrogen dependency in uterine endometrial cancers. Oncology 55 (Suppl 1): 53-59, 1998.
7. Matsumoto K and Noguchi S: Hormone therapy - recent advances. Gan To Kagaku Ryoho 14: 2816-2823, 1987.
8. Vihko R, Alanko A, Isomaa V and Kauppila A: The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer. Med Oncol Tumor Pharmacother 3: 197-210, 1986. (Pubitemid 17219214)
9. Bentwich I: Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910, 2005. (Pubitemid 41484136)
10. Zhao Y, Ransom JF, Li A, et al: Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 1-15, 2007.
11. Kumamoto K, Spillare EA, Fujita K, et al: Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b and mir-34c expression, and induce senescence. Cancer Res 68: 3193-3203, 2008.
12. Tazawa H, Tsuchiya N, Izumiya M, et al: Tumor-suppressive mir-34a induces senescence-like growth arrest through modulation of the e2F pathway in human colon cancer cells. Proc natl acad Sci uSa 104: 15472-15477, 2007. (Pubitemid 47502941)
13. Xia L, Zhang D, Du R, et al: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008. (Pubitemid 351842022)
14. Asangani IA, Rasheed SA, Nikolova DA, et al: microRNA-21 (mir-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
15. Harris TA, Yamakuchi M, Ferlito M, et al: microRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516-1521, 2008. (Pubitemid 351346546)
16. John B, Sander C and Marks DS: Prediction of human microRNA targets. Methods Mol Biol 342: 101-113, 2006.
17. Tan DS, Lambros MB, Marchiò C and Reis-Filho JS: ESR1 amplification in endometrial carcinomas: Hope or hyperbole? J Pathol 216: 271-274, 2008.